Share this Post!

In the interest of service and due to the COVID-19 pandemic, the effectivity of FDA Circular No. 2020-009 entitled “Guidelines on the Identification, Notification, Evaluation, Regulatory Enforcement Action, and Review and Monitoring of Donated Health Products Solely Intended to Address Covid-19 Public Health Emergency” is hereby extended until 31 August 2020.

For your information and guidance.

Attachment:->FDA Circular No. 2020-009-C